The requirements for molecular diagnostics in the certified lung cancer centres are based on the strong recommendations and quality indicators of the German S3-guideline and require molecular diagnostics for relevant mutations in NSCLC stage IV and EGFR and ALK analysis in anatomical resected stage IB-IIIA. This evidence concerns the gene EGFR and lung carcinoma.